Intrinsiqq
Cencora, Inc. logo

Cencora, Inc. (COR) Insider Trading

Last 12 months

Insiders bought $2.31M and sold $15.1M on the open market.

52% of the selling was scheduled in advance under 10b5-1 plans. Executive Vice President Elizabeth S Campbell sold $3.66M on Aug 24, 37% of their stake, outside a plan.

Net open-market
−$12.7M
3 buys · 12 sales
Under a 10b5-1 plan
52%
of the value sold
Insiders who bought / sold
2 / 5
executives and directors
Last open-market buy
Jun 2026
Jun 22, 2026

Get an email when COR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 110b5-1 plan
    Lazarus Krikorian
    SVP & Chief Accounting Officer · sold 986 at $303.18
    $299k
    6.1% of stake
  • Sep 16No plan
    Lon R Greenberg
    Director · sold 1,280 at $321.30
    $411k
    7.0% of stake
  • Sep 110b5-1 plan
    Lazarus Krikorian
    SVP & Chief Accounting Officer · sold 985 at $325.97
    $321k
    5.7% of stake
  • Aug 24No plan
    Elizabeth S Campbell
    Executive Vice President · sold 11,300 at $324.12
    $3.66M
    37% of stake
  • Jun 22
    Lauren M Tyler
    Director · bought 550 at $270.23
    $149k
    14% of stake
  • Jun 18
    Dermot Mark Durcan
    Director · bought 4,000 at $274.19
    $1.1M
    14% of stake
  • May 28
    Dermot Mark Durcan
    Director · bought 4,000 at $266.26
    $1.07M
    17% of stake
  • Feb 2010b5-1 plan
    Robert P. Mauch
    President & CEO · sold 3,762 at $358.94
    $1.35M
    5.4% of stake
  • Feb 1810b5-1 plan
    Robert P. Mauch
    President & CEO · sold 1,333 at $359.46
    $479k
    2.0% of stake
  • Jan 2010b5-1 plan
    Robert P. Mauch
    President & CEO · sold 5,096 at $354.73
    $1.81M
    7.1% of stake
  • Dec 19, 2025No plan
    Elizabeth S Campbell
    Executive Vice President · sold 3,351 at $342.10
    $1.15M
    12% of stake
  • Dec 19, 2025No plan
    Silvana Battaglia
    Executive Vice President · sold 1,677 at $345.00
    $579k
    8.2% of stake
  • Dec 18, 202510b5-1 plan
    Robert P. Mauch
    President & CEO · sold 5,096 at $343.45
    $1.75M
    7.0% of stake
  • Dec 17, 2025No plan
    Lazarus Krikorian
    SVP & Chief Accounting Officer · sold 4,031 at $343.24
    $1.38M
    19% of stake
  • Nov 18, 202510b5-1 plan
    Robert P. Mauch
    President & CEO · sold 5,096 at $366.64
    $1.87M
    7.2% of stake
  • Oct 20, 202510b5-1 plan
    Robert P. Mauch
    President & CEO · sold 5,097 at $326.80
    $1.67M
    12% of stake
  • Oct 1, 202510b5-1 plan
    Elizabeth S Campbell
    Executive Vice President · sold 1,886 at $313.28
    $591k
    13% of stake
  • Sep 18, 202510b5-1 plan
    Robert P. Mauch
    President & CEO · sold 5,097 at $290.00
    $1.48M
    11% of stake
  • Sep 16, 202510b5-1 plan
    Steven H Collis
    Executive Chairman · sold 31,350 at $289.86
    $9.09M
    9.3% of stake
  • Aug 19, 202510b5-1 plan
    Steven H Collis
    Executive Chairman · sold 14,579 at $289.98
    $4.23M
    4.5% of stake
  • Aug 18, 202510b5-1 plan
    Robert P. Mauch
    President & CEO · sold 4,968 at $293.53
    $1.46M
    11% of stake
  • Jul 22, 202510b5-1 plan
    Steven H Collis
    Executive Chairman · sold 14,578 at $292.67
    $4.27M
    4.5% of stake
  • Jul 18, 202510b5-1 plan
    Robert P. Mauch
    President & CEO · sold 4,968 at $294.11
    $1.46M
    10% of stake
  • Jun 24, 202510b5-1 plan
    Steven H Collis
    Executive Chairman · sold 14,579 at $292.62
    $4.27M
    4.5% of stake
  • Jun 18, 2025No plan
    Silvana Battaglia
    Executive Vice President · sold 4,077 at $297.41
    $1.21M
    27% of stake
  • Jun 18, 202510b5-1 plan
    Robert P. Mauch
    President & CEO · sold 4,969 at $295.30
    $1.47M
    10% of stake
  • May 29, 2025No plan
    Lazarus Krikorian
    SVP & Chief Accounting Officer · sold 3,000 at avg $288.96
    $867k
    15% of stake
  • May 20, 202510b5-1 plan
    Steven H Collis
    Executive Chairman · sold 14,578 at $293.84
    $4.28M
    4.4% of stake
  • May 19, 202510b5-1 plan
    Robert P. Mauch
    President & CEO · sold 4,969 at $291.43
    $1.45M
    9.8% of stake
  • May 14, 2025No plan
    Lon R Greenberg
    Director · sold 3,000 at $279.05
    $837k
    14% of stake
  • Apr 22, 202510b5-1 plan
    Steven H Collis
    Executive Chairman · sold 14,579 at $281.81
    $4.11M
    4.4% of stake
  • Apr 21, 202510b5-1 plan
    Robert P. Mauch
    President & CEO · sold 4,969 at $289.33
    $1.44M
    9.5% of stake
  • Mar 25, 202510b5-1 plan
    Steven H Collis
    Executive Chairman · sold 14,578 at avg $269.51
    $3.93M
    4.4% of stake
  • Mar 24, 202510b5-1 plan
    Elizabeth S Campbell
    Executive Vice President · sold 4,127 at avg $268.28
    $1.11M
    22% of stake
  • Mar 18, 202510b5-1 plan
    Robert P. Mauch
    President & CEO · sold 4,970 at avg $260.93
    $1.3M
    9.2% of stake
  • Mar 10, 2025No plan
    Lazarus Krikorian
    SVP & Chief Accounting Officer · sold 2,000 at $260.06
    $520k
    9.0% of stake
  • Mar 3, 202510b5-1 plan
    Robert P. Mauch
    President & CEO · sold 4,970 at avg $255.00
    $1.27M
    8.9% of stake
  • Feb 27, 202510b5-1 plan
    Steven H Collis
    Executive Chairman · sold 14,579 at avg $251.08
    $3.66M
    4.4% of stake
  • Feb 21, 2025No plan
    Silvana Battaglia
    Executive Vice President · sold 5,000 at $242.24
    $1.21M
    25% of stake
  • Feb 6, 2025No plan
    Walgreens Boots Alliance Holdings LLC
    Large holder · sold 1,286,376 at avg $244.51
    $315M
    9.3% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch COR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Wholesale-Drugs, Proprietaries & Druggists' Sundries

Spot a number that looks wrong? Check it in COR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing COR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.